To examine the expression levels of RSK1 and RSK2, tumor mRNA levels were analyzed from the gene expression profiling interactive analysis (GEPIA2) which computed TCGA data in the form of transcripts per million. The gene discussed is RPS6KA1; the disease is neoplasm.